Argyriou K, Kotsakis A. Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”. World J Clin Cases 2022; 10(23): 8425-8427 [PMID: 36159549 DOI: 10.12998/wjcc.v10.i23.8425]
Please LOGIN to submit a new comment.